Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences CRO/Sponsor Summit on Data Integrity in Clinical Research

C N Ramchand's Biography



C N Ramchand, Chief Executive Officer

Dr CN Ramchand, a British Citizen, is currently the President and CEO of Saksin life sciences Pvt. Ltd, and MagGenome Technologies Pvt Ltd a start-up biotech company and Advisor to SciGenom Research Foundation, MedGenome Pvt Ltd and SciGenome Pvt Ltd. Earlier to this he served as the President and CEO of Laila Pharmaceuticals Pvt. Ltd., a Drug Discovery Company based at Chennai with the Head Office at Vijayawada. Previous to this position, Dr. Ramchand was the Director, at KEMIN Pharma, India (A subsidiary of Kemin Pharma Belgium BVBA) and was holding a simultaneous position as Director of Research and Development, Kemin Industries South Asia Pvt. Ltd., a part of Kemin Industries Inc, Desmoines, USA. Dr. Ramchand was also a worldwide executive team member at Kemin Industries. Prior to the assignment at Kemin Industries, Dr Ramchand was with Sun Pharmaceuticals, currently the largest Pharma company in India (as per ORG marg) as its Vice President and Head of Drug Discovery Research (Biological Research Programme) (1999-2004). He was closely involved in the setting up of a multimillion Drug Discovery centre including design and development of laboratories. Currently, Dr Ramchand is an Honorary Visiting Professor to European Nanotechnology consortium at University of Newcastle, UK. He is also an adjunct faculty, Visiting Professor and PhD guide at Swinburne University of technology, Australia along with Prof. Ajay Kapoor.
Dr. Ramchand is a PhD in Biochemistry from MS University Baroda. He also served as assistant professor (1982-84) at MS University. He has also obtained his M Phil from the same university. He did his Bachelor’s degree in Chemistry at S.D College, Alleppey from 1972 -75. He holds a Masters degree in Chemistry from the University of Kerala. He has also won the Young Scientist award from Charing Cross and Westminster Medical School, UK for 3 times, for the work in the role of membrane pathology in schizophrenia and the development of EPA as a therapy for schizophrenia. He has extensive experience in basic research activities, having handled prestigious projects in the US&UK, both Universities and in the Pharma Industry. He has over 25 years of rich experience in the areas of teaching, basic research, Drug discovery programme and disease mechanisms, guiding M Sc. / Ph D. students and setting up Research facility.
Dr Ramchand has closely worked on several molecules and many of these molecules are at different stages of Clinical trials. He has also held the position of Joint coordinator and Head, Laboratory research program at biomedical sciences, University of Sheffield and Northern General Hospital Sheffield, UK (1994-1999), a prestigious University Position. Prior to this he was the Sr. Scientist and Project Head at the Institute of Biological Psychiatry at University of Wales, Bangor UK (1990-1994). He has also worked as Senior Research Officer at the Biochemistry Department, University of North Wales, Bangor, UK (1987-1990). Prior to this he was also a postdoctoral fellow at University of South Carolina, USA (1984-1987)
Dr. Ramchand has published over 70 peer-reviewed papers in international journals, edited 5 books, has 3 patented products and has applied for over 15 patents. He has done over 100 research presentations at International conferences worldwide and was also a senior Visiting fellow at University of Sheffield and University of New Castle Upon-Tyne, UK, and at Slovakian Academy of Sciences, Slovak Republic. He has a very close research association with State University of New York at Buffalo, USA, Florida International University and also is an adjunct faculty and PhD guide at the MS University of Baroda.

C N Ramchand Image